-
Stakeholder Involvement in the Health Technology Assessment Process in Ukraine
Sep 9, 2025, 16:22 PM -
Recent Changes in HTA and Reimbursement Requirements: Learnings for Global Dossiers
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Lu-PSMA Therapy Compared to Taxane-Based Cabazitaxel in Patients Diagnosed With Metastatic Castration-Resistant Prostate Cancer: A Colombian Health System Perspective
Sep 9, 2025, 16:22 PM -
Evaluating Digital Health Tools in the UK for Type 1/2 Diabetes: An Overview of the Evidence Critiques
Sep 9, 2025, 16:22 PM -
Strategic Cost Management in Health Insurance: A Governance Model for EPS-IPS Alignment in Colombia’s Caribbean Region
Sep 9, 2025, 16:22 PM -
Group A Streptococcal Infections—Diagnostic Approaches and Antibiotics Prescriptions in Children and Adolescents in Germany: A Nationwide Representative Claims Data Analysis
Sep 9, 2025, 16:22 PM -
A Nutrient-Dense Formula in Undernourished Children in Indonesia: An Effective Cost-Saving Strategy
Sep 9, 2025, 16:22 PM -
Multiple Myeloma Caregiver Costs and Disabilities Data for Economic Modeling and HTA Submissions
Sep 9, 2025, 16:22 PM -
Evolution in Hospital Bed Capacity in Hungary and Romania Between 1980 and 2020 With Special Focus on Regions Inhabited by Ethnic Minorities
Sep 9, 2025, 16:22 PM -
Systematic Review of Prognostic Factors for Efficacy and Safety Outcomes in CAR-T Cell Therapy for Diffuse Large B-cell Lymphoma
Sep 9, 2025, 16:22 PM -
Impact of SGLT2-Inhibitor Uptake in CKD Management in Denmark: A Decision Economic Model
Sep 9, 2025, 16:22 PM -
Exploring the Impact of Dupilimab on the Patient Care Pathways: GHG Emissions of Patients With Moderate-to-Severe COPD In France
Sep 9, 2025, 16:22 PM -
Screening and Diagnosis of Paroxysmal Nocturnal Hemoglobinuria in Greece: Consensus Recommendations From a Multispecialty Expert Panel
Sep 9, 2025, 16:22 PM -
Use of AI in Breast Cancer Screening in England Has a Minimal Impact on Greenhouse Gas Emissions and May Increase Diagnostic Accuracy
Sep 9, 2025, 16:22 PM -
Modeling the Public Health Impact of Nirsevimab and Maternal Vaccination With RSVpreF Against Infant Respiratory Syncytial Virus Infection in Germany
Sep 9, 2025, 16:22 PM -
How Long Do Beneficiaries Stay? A Real-World Data Study of Enrollment Time Across HMOs in Brazil’s Private Health System
Sep 9, 2025, 16:22 PM -
Patient Preference Research With AI-Lowered Evidence Generation
Sep 9, 2025, 16:22 PM -
AI for Pricing Reimbursement: When to Green-Light, When to Red-Light?
Sep 9, 2025, 16:22 PM -
Addressing Bias in Indirect Treatment Comparisons: A Framework for Identifying TEMs and PVs
Sep 9, 2025, 16:22 PM -
AI for Rapid Data Extraction: A Case Study on the Economic and Caregiver Burden of Motor Neuron Disease
Sep 9, 2025, 16:22 PM